Robert F. Halliwell, PhD
BSc, University of Stirling, Scotland, 1983
MSc, University of London, England, 1985
PhD, University of Dundee, Scotland, 1992
Post-graduate in Neurological Science, University of London
Post-graduate in Pharmacology, University of Dundee
Post-Doc in Neuroscience, University of California, Irvine
At Pacific Since: 2002
Robert F. Halliwell, PhD earned a bachelor of science from University of Stirling in Scotland and a master of science from University of London in England. He earned his doctor of philosophy from University of Dundee in Scotland. Dr. Halliwell completed post-graduate training in neurological science at University of London, in pharmacology at University of Dundee and short-term training at the Rockefeller University, the London School of Pharmacy and Universidad Nacional Autónoma de México. Before coming to Pacific he was a Research Fellow at University of California, Irvine. He joined the Pacific family in 2002.
Dr. Halliwell considers himself very fortunate and privileged to teach Pacific's pharmacy students because they are bright, hard-working and respectful. Dr. Halliwell's area of expertise is neuroscience in the context of clinical pharmacology. He is actively involved in the International Brain Research Organization. Dr. Halliwell gives community seminars and lectures on healthy brain aging and the potential value of stem cells in drug discovery and regenerative medicine. He is also on the Medical Ethics Committee at Dignity Health and the advisory board for the Wellness Center of San Joaquin.
Although he is English, the majority of his education took place in Scotland. He is learning to play the guitar as a left-hander, loves trail running and enjoys riding his 2015 Harley-Davidson Street Glide.
Teaching Philosophy: "If I make it interesting and sometimes fun, we all learn together."
PHRM122 - Physiology & Pathophysiology I
PHRM 146 - Therapeutics I Neuropsychiatry
PG220 - Pharmacology (DDS)
Research Summary: "Our lab is addressing the properties and potential value of neurons derived from a variety of human stem cells for studies in neuropharmacology and neurotoxicology; I have also published work in the history of medicine."
Robert F. Halliwell, PhD (Principal Investigator)
Leanne Coyne, PhD (Associate Professor)
William S. Cao, PhD (Post-Doctoral Researcher)
Kathleen L. Metz, BS (Graduate Student)
- Properties of Neurons Derived from Stem Cells
- Neurotransmitter Receptors and Ion Channels
- History of Medicine
Cao WS, Livesey JC & Halliwell RF. An evaluation of a human stem cell line to identify risk of developmental neurotoxicity with antiepileptic drugs. Toxicol In Vitro, 29 (3): 592-599 (2015).
Coyne L, Shan M, Przyborski SA, Hirakawa R & Halliwell RF. Neuropharmacological properties of neurons derived from human stem cells, Neurochemistry International, 59(3): 404-12 (2011).
Halliwell RF Letter from America: The Potential of Stem Cells, British Neuroscience Ass Bulletin, 61: 11 (2010).
C-R Pruell, A-H Maehle & RF Halliwell (Book). A Short History of the Drug Receptor Concept, Palgrave Macmillan (2009). ISBN-13: 9780230554153.
Khansari PS & Halliwell RF, Evidence for Neuroprotection by the Fenamate NSAID, Mefenamic Acid. Neurochemistry International, 55: 683-688 (2009).
Harris D, et al., Selective influence on contextual memory: physiochemical properties associated with selectivity of benzodiazepine ligands at GABAA receptors containing the α5 subunit. Journal of Medicinal Chemistry, 51: 3788-3803 (2008).
Halliwell, RF. A Short history on the rise of the molecular pharmacology of ionotropic drug receptors, Trends in Pharmacological Sciences, 28 (5): 214 - 219 (2007).
Coyne L, et al., Characterization of the interaction between fenamate NSAIDs and hippocampal neuron GABAA receptors. Neurochemistry International, 51: 440 - 446 (2007).
Johnstone TBC, et al., Antibacterial quinolones yield novel anxiolytics. Nature Medicine, 10 (1): 31-32 (2004).
Maehle, AH, Prüll, CR & Halliwell, RF. The emergence of the drug receptor theory. Nature Reviews, Drug Discovery, 1: 637-641 (2002).